Esaote brings I-Genius intraoperative MRI closer to U.S. market
The intraoperative MRI system is designed to support multiple MRI acquisitions during glioma surgery without repositioning the patient.

Esaote presented the latest developments of I-Genius, an open MRI system for intraoperative brain tumor imaging, at the American Association of Neurological Surgeons annual meeting in San Antonio. The meeting took place from May 1 to 4.
I-Genius is designed to support glioma surgery by allowing multiple MRI acquisitions during a procedure. Esaote said the system can provide imaging checks without moving the patient from the surgical table.
The platform is optimized for the surgical environment and intended to bring MRI verification steps into the operating room. Esaote said the approach is meant to support intraoperative decision-making during complex tumor removal.
Company materials describe a 1-room setup with 1 surgical table and a 1.7-meter safe zone. The system also includes tools such as a dedicated cranial fixation system, a 55-inch UHD monitor for real-time image display, and optional BrainNav neuronavigation by MedCom.
Glioma surgery can require assessment of residual tumor during resection. Esaote said intraoperative MRI is intended to help surgeons evaluate tumor removal during the procedure rather than after patient transfer.
I-Genius is pending U.S. Food and Drug Administration clearance and is not yet available for sale in the U.S., according to Esaote.
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
More from this section

AdvaHealth to present cloud-native imaging platform at SIIM 2026
The company will present AdvaPACS, AdvaPACS Worklist, and AdvaView at SIIM 2026, while introducing its Value-Based Imaging commercial framework.

Philips unveils Titanion ultra-high-gradient 3T MRI
Philips introduced Titanion MR, an ultra-high-gradient 3T MRI system, at ISMRM 2026. The work-in-progress system is designed for quantitative biomarker imaging in applications such as neurology and oncology.

SIIM, DPA launch joint conference pass
SIIM and the Digital Pathology Association launched the SIIM-DPA Bridge Pass, giving members bundled access to SIIM26 in Pittsburgh and Pathology Visions 2026 in San Diego through a single payment.